Brief: Homology Medicines Announces FDA Lifted Clinical Hold On Phenix Gene Therapy Trial For Pku
June 13 (Reuters) - Homology Medicines Inc FIXX.O :
* HOMOLOGY MEDICINES ANNOUNCES FDA LIFTED CLINICAL HOLD ON
PHENIX
GENE THERAPY TRIAL FOR PKU
* HOMOLOGY MEDICINES - FDA NOTED IN RESPONSE THAT CO
SATISFACTORILY ADDRESSED ALL CLINICAL HOLD ISSUES IDENTIFIED IN
ITS LETTER OF MARCH 17, 2022
Source text for Eikon: ID:nGNX1nkyPr
Further company coverage: FIXX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Q32 Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Q32 Bio Reports Second Quarter 2026 Financial Results And Provides Corporate Update
Q32 Bio Inc. reports results for the quarter ended June 30 - Earnings Summary
Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview